PATENT CLAIM ANALYSIS

Application Number: 16131812
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "171000"]

Abstract:
The present disclosure provides methods of treating inflammation of the upper gastrointestinal tract, especially the esophagus, by administering an oral corticosteroid. In some cases, the methods include treating eosinophilic esophagitis (EoE) by administering an oral corticosteroid in an induction phase and a maintenance phase to improve peak eosinophilic counts and symptoms. In embodiments, the methods include treating EoE by administering the oral corticosteroid at nighttime and/or while the patient is lying down.

Claim (Index 5):
The method of  claim 1 , wherein the patient does not eat or drink for at least about 30 minutes after administration the oral corticosteroid.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 97.0
- Lexical Diversity: 1.62
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15680301', '14485017', '12269572', '14851695', '12269650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7070199633353581
- 35 USC 102 Novelty (BERT): 0.6641895691643575
- Combined Prediction Score: 0.702736923918258
- Mean Citation Score: 336.623794
- Max Citation Score: 646.221
- Similarity Product: 608.8326835107207

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test